NCT06098560View on ClinicalTrials.gov

Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Colorectal Cancer

Trial Locations (2)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

Unknown

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Geneplus-Beijing Co. Ltd.

INDUSTRY